Precision Biosciences (DTIL) Total Debt (2021 - 2026)

Precision Biosciences (DTIL) has 6 years of Total Debt data on file, last reported at $22.4 million in Q1 2026.

• On a quarterly basis, Total Debt changed 0.37% year-over-year to $22.4 million in Q1 2026; TTM through Mar 2026 was $22.4 million, a 0.37% change from a year earlier, with the FY2025 full-year figure at $22.4 million, changed 0.37% from the prior year.
• Total Debt for Q1 2026 stood at $22.4 million, roughly flat from $22.4 million in the prior quarter.
• Over the last five years, Total Debt for DTIL reached as high as $22.5 million in Q2 2024 and fell as low as $2.5 million in Q1 2022.
• Historically, Total Debt has averaged $21.2 million across 5 years, with a median of $22.3 million in 2025.
• Across the five-year window, Total Debt jumped 809.87% in 2022 and dropped 0.62% in 2025, its largest moves.
• Year by year, Total Debt stood at $22.2 million in 2022, then advanced by 0.85% to $22.4 million in 2023, then dropped by 0.41% to $22.3 million in 2024, then gained by 0.37% to $22.4 million in 2025, then gained by 0.07% to $22.4 million in 2026.
• Per Business Quant data, the three most recent Total Debt figures were $22.4 million in Q1 2026, $22.4 million in Q4 2025, and $22.4 million in Q3 2025.